Preliminary reports show conolidine may well inhibit specific ion channels, lowering neuronal excitability and restricting ache signals. This system is especially appropriate in neuropathic pain, in which abnormal signaling results in persistent discomfort. Also, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to pain notion. Computational docking https://damienc813eax3.blogdomago.com/profile